Objective: With limited data available on calcification prevalence in chronic kidney disease
(CKD) patients on dialysis, the China Dialysis Calcification Study (CDCS) determined the …

Background Cardiac valve calcification (CVC) is highly prevalent and a risk factor for
adverse outcomes in patients with chronic kidney disease (CKD). This meta-analysis aimed …

Cardiovascular (CV) disease is highly prevalent in the population with chronic kidney
disease (CKD), where the risk of CV death in early stages far exceeds the risk of progression …

Background: Few studies have evaluated the viability and outcomes between peritoneal
dialysis (PD) and haemodialysis (HD) in urgent-start renal replacement therapy (RRT). This …

Background Coronary artery calcification (CAC) is associated with cardiovascular mortality
in end-stage renal disease (ESRD) patients. The present study aimed to identify modifiable …

Cardiac valve calcification (CVC), characterized by the accumulation of calcium in the heart
valves, is highly prevalent among patients undergoing dialysis. This meta-analysis aimed to …

Background: Vascular calcification is seen in most patients on dialysis and is strongly
associated with cardiovascular mortality. Vascular calcification is promoted by phosphate …

Background Phosphorus control is generally considered to be better in peritoneal dialysis
(PD) patients as compared with haemodialysis (HD) patients. Predialysis phosphorus …

Background The purpose of the study was to compare the risk of de novo cardiovascular
disease (CVD) between hemodialysis (HD) and peritoneal dialysis (PD) in patients with …

Background: A database analysis was conducted to assess the effectiveness of sucroferric
oxyhydroxide (SO) on lowering serum phosphorus and phosphate binder (PB) pill burden …